[
1. Sengupta S, Chattopadhyay MK, Grossart, HP: The multifaceted roles of antibiotics and antibiotic resistance in nature. Front Microbiol 2013, 4 (47).10.3389/fmicb.2013.00047359498723487476
]Search in Google Scholar
[
2. Capita R, Alonso-Calleja C: Antibiotic-Resistant Bacteria: A Challenge for the Food Industry. Crit Rev Food Sci Nutr 2013, 53: 11–48.10.1080/10408398.2010.51983723035919
]Search in Google Scholar
[
3. Van Boeckel TP, Brower C, Gilbert M, Grenfell BT, Levin SA, Robinson TP, Teillant A, Laxminarayan R: Global trends in Antimicrobial use in food animals. Proc Natl Acad Sci 2015, 112: 5649–5654.10.1073/pnas.1503141112442647025792457
]Search in Google Scholar
[
4. WHO. Global Action Plan on Antimicrobial Resistance; World Health Organization: Geneva, Switzerland, 2015.
]Search in Google Scholar
[
5. EMA (2016). Available online: https://www.ema.europa.eu/en/medicines/veterinary/EPAR/zuprevo#authorisationdetails-section (accessed on 16 March 2021)
]Search in Google Scholar
[
6. Menge M, Rose M, Bohland C, Zschiesche E, Kilp S, Metz W, et al: Pharmacokinetics of tildipirosin in bovine plasma, lung tissue, and bronchial fluid (from live, nonanesthetized cattle). J Vet Pharmacol Ther 2012, 35: 550–559.10.1111/j.1365-2885.2011.01349.x22188102
]Search in Google Scholar
[
7. Rose M, Menge M, Bohland C, Zschiesche E, Wilhelm C, Kilp S, et al: Pharmacokinetics of tildipirosin in porcine plasma, lung tissue, and bronchial fluid and effects of test conditions on in vitro activity against reference strains and field isolates of Actinobacillus pleuropneumoniae. J Vet Pharmacol Ther 2013, 36 (2): 140–153.10.1111/j.1365-2885.2012.01397.x22500881
]Search in Google Scholar
[
8. Wang J, Zhao T, Sun X, Liu Y, Zhu J, Zhang S, et al: Pharmacokinetics of tildipirosin in beagle dogs. J Vet Pharmacol Ther 2018, 41 (1): e49–e52.10.1111/jvp.1245328892155
]Search in Google Scholar
[
9. Xiong J, Xu Y, He S, Zhang Y, Wang Z, Wang S, Jiang H: Pharmacokinetics and bioavailability of tildipirosin in rabbits following single-dose intravenous and intramuscular administration. J Vet Pharmacol Ther 2020, 43: 448–453.10.1111/jvp.1288232542744
]Search in Google Scholar
[
10. Galecio JS, Escudero E, Cerón JJ, Crescenzo G, Marín P: Pharmacokinetics of tildipirosin in ewes after intravenous, intramuscular and subcutaneous administration. Animals 2020, 10: 1332.10.3390/ani10081332746042032752202
]Search in Google Scholar
[
11. Arsic B, Barber J, Č ikoš A, Mladenovic M, Stankovic N, Novak P: 16-membered macrolide antibiotics: a review. Int J Antimicrob Agents 2018, 51(3): 283-298.10.1016/j.ijantimicag.2017.05.02028668674
]Search in Google Scholar
[
12. Zeng D, Sun M, Lin Z, Li M, Gehring R, Zeng Z: Pharmacokinetics, and pharmacodynamics of tildipirosin against Pasteurella multocida in a murine lung infection model. Front Microbiol 2018, 9, 1038.10.3389/fmicb.2018.01038596819329867911
]Search in Google Scholar
[
13. Abu-Basha EA, Bani Ismail Z, Abu Alhaijaa H, Hamzeh E, Idkaidek NM: Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in sheep. J Vet Pharmacol Ther 2021, 44: 79–85.10.1111/jvp.1290132748450
]Search in Google Scholar
[
14. Lei Z, Liu Q, Yang B, Ahmed S, Cao J, He Q: The pharmacokinetic-pharmacodynamic modeling and cut-off values of tildipirosin against Haemophilus parasuis. Oncotarget 2018, 9: 1673-1690.10.18632/oncotarget.23018578859029416722
]Search in Google Scholar
[
15. Elazab ST, Badawy ME: Pharmacokinetics and bioavailability of tildipirosin in goats using HPLC. JJVR 2020, 68 (1): 5-12.
]Search in Google Scholar
[
16. Abu-Basha EA, Bani Ismail Z, Ababneh MM, Hamzeh E, Gehring R: Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in horses. J Vet Pharmacol Ther 2021, 44: 544-551.10.1111/jvp.1295833609061
]Search in Google Scholar
[
17. Food and Drug Administration. U.S. Department of Health and Human Services, Bioanalytical Method Validation Guidance for Industry., U.S. Dep. Heal. Hum. Serv. Food Drug Adm. (2018) 1–41. https://www.fda.gov/files/drugs/published/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf
]Search in Google Scholar
[
18. Wang J, Leung D, Chow W, Chang J, Wong JW: Target screening of 105 veterinary drug residues in milk using UHPLC/ESI Q-Orbitrap multiplexing data independent acquisition. Anal Bional Chem 2018, 410: 5373-5389.10.1007/s00216-017-0847-z29404665
]Search in Google Scholar
[
19. Castilla-Fernández D, Moreno-González D, Beneito-Cambra M, Molina-Díaz A: Critical assessment of two sample treatment methods for multiresidue determination of veterinary drugs in milk by UHPLC-MS/MS. Anal Bional Chem 2019, 41: 1433-1442.10.1007/s00216-019-01582-y30683965
]Search in Google Scholar
[
20. Wang H, Ren L, Yu X, Hu J, Chen Y, He G, Jiang Q: Antibiotic residues in meat, milk and aquatic products in Shanghai and human exposure assessment. Food Cont 2017, 80: 217-225.10.1016/j.foodcont.2017.04.034
]Search in Google Scholar
[
21. Zhou W, Yang S, Wang P G: Matrix effects and aplication of matrix effect factor. Bioanalysis 2017, 9 (23): 1839-1844.10.4155/bio-2017-021429171768
]Search in Google Scholar
